A complete cross-over design evaluating canine acceptance of Carprieve® and Rimadyl® carprofen chewable tablets in healthy dogs

BACKGROUND: Osteoarthritis (OA) affects nearly 20% of all dogs greater than one year of age. Clinical signs include pain, discomfort, lameness, and ultimately lead to disability. Although there is currently no known cure, there are many therapeutic options that can slow the progression and alleviate...

Descripción completa

Detalles Bibliográficos
Autores principales: Dewsbury, Diana M. A., DeDonder, Keith D., Rezac, Darrell J., Cernicchiaro, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833212/
https://www.ncbi.nlm.nih.gov/pubmed/31690309
http://dx.doi.org/10.1186/s12917-019-2124-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833212/
https://www.ncbi.nlm.nih.gov/pubmed/31690309
http://dx.doi.org/10.1186/s12917-019-2124-1

Ejemplares similares